Aims: To assess long-term prognosis in patients with functional mitral regurgitation (FMR ... current standard pharmacological therapy. Moderate-to-severe MR is an independent predictor of ...

The condition of predominant moderate aortic regurgitation could be ameliorated with the rheumatic mitral valve (MV) surgery. What is known and what is new? • During MV surgery, aortic valve ...

We conducted a randomized, controlled trial involving patients with heart failure and moderate to severe functional mitral regurgitation from 30 sites in nine countries. The patients were assigned ...

Of the 614 patients enrolled in the trial, 302 were assigned to the device group and 312 to the control group. The annualized rate of hospitalization for heart failure through 5 years was 33.1% ...

The AltaValve™ System is designed for treating patients with moderate or severe mitral regurgitation (MR). AltaValve treats MR by implanting a prosthetic valve via a catheter which regulates ...

Mitral transcatheter edge-to-edge repair (M-TEER) reduced cardiovascular death and heart failure (HF)-related hospitalizations with improved health status in patients with HF and moderate to ...

Patients in a study with heart failure who identified as having mitral regurgitation saw a doubling of creatinine. Of the 600 patients in the study, 71 had moderate or severe mitral regurgitation.

PARIS--(BUSINESS WIRE)--HighLife SAS, a medtech company focused on the development of a novel Trans-Septal Mitral Valve Replacement (“TSMVR”) system to treat patients suffering from moderate ...